Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4436174)

Published in PLoS One on May 18, 2015

Authors

Kristin A Guertin1, Fangyi Gu2, Sholom Wacholder3, Neal D Freedman1, Orestis A Panagiotou3, Carolyn Reyes-Guzman2, Neil E Caporaso2

Author Affiliations

1: Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, United States of America.
2: Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, United States of America.
3: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, United States of America.

Articles cited by this

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91

Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med (2011) 6.56

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials (2000) 6.17

Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54

Current cigarette smoking among adults - United States, 2005-2012. MMWR Morb Mortal Wkly Rep (2014) 4.39

Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27

Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46

A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med (1993) 2.28

Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med (1999) 1.91

Estimation of cigarette smoking-attributable morbidity in the United States. JAMA Intern Med (2014) 1.82

Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev (2009) 1.69

Time to smoke first morning cigarette and lung cancer in a case-control study. J Natl Cancer Inst (2014) 1.66

Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65

Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest (2001) 1.44

Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev (2006) 1.23

Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 1.20

Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med (2010) 1.17

How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther (1983) 1.16

Nicotine dependence, motivation to quit, and diagnosis among adult emergency department patients who smoke: a national survey. Nicotine Tob Res (2008) 1.13

Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res (2011) 1.10

Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulm Med (2014) 1.04

Nicotine dependence phenotype and lung cancer risk. Cancer (2011) 1.00

Time to first cigarette and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels in adult smokers; National Health and Nutrition Examination Survey (NHANES), 2007-2010. Cancer Epidemiol Biomarkers Prev (2013) 0.97

The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers. Addiction (2013) 0.94

A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma (2008) 0.89

Lung cancer risk measured by the Fagerström Test for Nicotine Dependence? Nicotine Tob Res (2007) 0.86

Nicotine dependence and urge to smoke predict negative health symptoms in smokers. Prev Med (2008) 0.85

Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res (2004) 0.83

The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes Control (2012) 0.83

Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine Tob Res (2012) 0.79